HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Launches Crest Densify Toothpaste, Mouthwash Formulated To Re-mineralize Enamel

Executive Summary

While active ingredient stannous fluoride is standard for toothpastes, firm says its product’s “premium formula,” used twice a day, re-hardens enamel and prevents future decay by creating 24-hour density protection against density loss.

You may also be interested in...



US Q1 Consumer Health Earnings Preview: Pivoting From Planning Changes To Parsing Results

Inflation's impact on consumer spending will be front and center in sector’s quarterly reports, beginning with J&J on 19 April. Potential impact also from price hikes common from most firms since early 2021 in response to increasing costs. Russia’s invasion of Ukraine also will prompt comment.

Colgate, P&G Extend Teeth Whitening Lines

Colgate Optic White line with Pro Series teeth-whitening toothpaste contains 5% hydrogen peroxide; P&G’s Crest Whitening Emulsions + Overnight Freshness offers convenience of overnight use.

P&G Extends Oral-B Brush Line With iOSense

Brush “provides live coaching” through embedded iOSense Charger to guide time, pressure and coverage without needing to watch smartphone app. Firm also extending Oral-B iO lineup with lower-priced iO4 and iO5 brushes available nationwide in the US beginning later in 2022.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS152357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel